RIL
AVXL icon

Rothschild Investment LLC’s Anavex Life Sciences AVXL Stock Holding History

Rothschild Investment LLC’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Buy
723
+239
+49% +$707 ﹤0.01% 2788
2026
Q1 		$1.49K Buy
484
+372
+332% +$1.61K ﹤0.01% 2688
2025
Q4 		$399 Sell
112
-143
-56% -$876 ﹤0.01% 2980
2025
Q3 		$2.27K Sell
255
-75
-23% -$761 ﹤0.01% 2153
2025
Q2 		$3.04K Buy
330
+95
+40% +$811 ﹤0.01% 1776
2025
Q1 		$2.02K Hold
235
– – ﹤0.01% 1892
2024
Q4 		$2.52K Buy
235
+135
+135% +$1.04K ﹤0.01% 1661
2024
Q3 		$568 Buy
100
+40
+67% +$231 ﹤0.01% 2434
2024
Q2 		$253 Buy
+60
New +$243 ﹤0.01% 2386

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rothschild Investment LLC's AVXL Position: Q2 2026 in Review

Rothschild Investment LLC increased its Anavex Life Sciences (AVXL) stake by 49% in Q2 2026, buying an estimated $707 and bringing the position to 723 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Rothschild Investment LLC first reported a position in AVXL in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.04K in Q2 2025. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Rothschild Investment LLC held 723 shares of Anavex Life Sciences worth $1.87K as of Q2 2026.
  • Rothschild Investment LLC bought 239 Anavex Life Sciences shares in Q2 2026, an estimated $707.
  • Anavex Life Sciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2788 holding.
  • Rothschild Investment LLC first reported a position in Anavex Life Sciences in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Anavex Life Sciences position peaked at $3.04K in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.